Related references
Note: Only part of the references are listed.The manifold actions of endocannabinoids on female and male reproductive events
Monica Bari et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
WARNING: LEGAL SYNTHETIC CANNABINOID-RECEPTOR AGONISTS SUCH AS JWH-018 MAY PRECIPITATE PSYCHOSIS IN VULNERABLE INDIVIDUALS
Susanna Every-Palmer
ADDICTION (2010)
In vitro phase I metabolism of the synthetic cannabimimetic JWH-018
Annette Wintermeyer et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders
Tiziana Bisogno et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity
Matthias Karst et al.
DRUGS (2010)
Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats
Pavel Mares et al.
EPILEPSIA (2010)
Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
Andrew J. Hill et al.
EPILEPSIA (2010)
Detection of JWH-018 metabolites in smoking mixture post-administration urine
Tim Sobolevsky et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products
Nahoko Uchiyama et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
The endocannabinoid signaling system: a marriage of PUFA and musculoskeletal health
Bruce A. Watkins et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
Roles of β- and α2-Adrenoceptors Within the Central Nucleus of the Amygdala in the Visceral Pain-Induced Aversion in Rats
Satoshi Deyama et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
Nicholas A. Jones et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Mutations in GABAA receptor subunits associated with genetic epilepsies
Robert L. Macdonald et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders
Massimo Mantegazza et al.
LANCET NEUROLOGY (2010)
A Teenager With Agitation Higher Than She Should Have Climbed
David Vearrier et al.
PEDIATRIC EMERGENCY CARE (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Panic Attack after Spice Abuse in a Patient with ADHD
H. Mueller et al.
PHARMACOPSYCHIATRY (2010)
Human amygdala reactivity is diminished by the β-noradrenergic antagonist propranolol
R. Hurlemann et al.
PSYCHOLOGICAL MEDICINE (2010)
Dopaminergic Dysfunction in Schizophrenia: Salience Attribution Revisited
Andreas Heinz et al.
SCHIZOPHRENIA BULLETIN (2010)
The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes
Helge Mueller et al.
SCHIZOPHRENIA RESEARCH (2010)
Spice drugs as a new trend: Mode of action, identification and legislation
I. Vardakou et al.
TOXICOLOGY LETTERS (2010)
Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product
Nahoko Uchiyama et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2009)
'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
Volker Auwaerter et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Effects of Δ9-tetrahydrocannabivarin on [35S] GTPγS binding in mouse brain cerebellum and piriform cortex membranes
I. Dennis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice
Arash Bahremand et al.
EPILEPSY RESEARCH (2008)
Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice
Shervin Gholizadeh et al.
NEUROPHARMACOLOGY (2007)
Anticonvulsant, antiepileptogenic, and antiictogenic pharmacostrategies
M. Holtkamp et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS
Qiang Zhang et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2006)
In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands
M. G. Cascio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Activation of G-proteins in brain by endogenous and exogenous cannabinoids
SR Childers
AAPS JOURNAL (2006)
Toxicokinetics of drugs of abuse: Current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine
HH Maurer et al.
THERAPEUTIC DRUG MONITORING (2006)
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors
JL Shoemaker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
MM Aung et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Share Paper
